Prisons fight opioids with $1,000 injection: Does it work?

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

SHERIDAN, Ill. (AP) _ U.S. prisons are experimenting with a high-priced monthly injection that could help addicted inmates stay off opioids after they are released.

It’s called Vivitrol. And proponents say it could be effective in the fight against the opioid epidemic affecting 2 million Americans and a portion of the prison population.

Vivitrol isn’t habit-forming, unlike older drugs like methadone, which can be abused.

But it costs significantly more _ abot $1,000 a month, compared with methadone which runs about $30 a month. Skeptics question its effectiveness and say the manufacturer has pushed an unproven drug onto corrections officials.

Supporters say Vivitrol can save money by keeping people from returning to prison. It costs $25,000 a year to house an inmate at Sheridan Correctional Center in Illinois, which is starting a Vivitrol program.

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.